Breast Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Phase 2 Terminated
3 enrolled 6 charts
SOLE-EST
Completed
104 enrolled 13 charts
Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27
Completed
364 enrolled
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
PACE in BC
Completed
133 enrolled
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Completed
363 enrolled
SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897
Completed
1,577 enrolled
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Completed
140 enrolled
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
Unknown
1,881 enrolled
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
Unknown
1,800 enrolled
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Phase NA Unknown
2,200 enrolled
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
Unknown
2,300 enrolled
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
Unknown
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
Unknown
6,000 enrolled
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Phase 1 Withdrawn
Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100
Completed
500 enrolled
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
Withdrawn
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
Completed
190 enrolled
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery
Phase 3 Completed
3,400 enrolled
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
Unknown
10,000 enrolled